SPOTCLAV 625 MG TABLET USP 2 X `7

Co-amoxiclav is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1):

•  Acute bacterial sinusitis (adequately diagnosed)
•  Acute otitis media
•  Acute exacerbations of chronic bronchitis (adequately diagnosed)
•  Community acquired pneumonia
•  Cystitis
•  Pyelonephritis
•  Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.
•  Bone and joint infections, in particular osteomyelitis.
• Consideration should be given to official guidance on the appropriate use of antibacterial agents.